Final Analysis of a Randomized Phase 1b Trial to Assess Sequencing of the E39 and E39' Vaccines to Optimize Long-Term Antitumor Immunity in Folate Binding Protein (FBP) Expressing Tumors
Authors:
- Kaitlin PeaceKPKaitlin Peace
- Timothy VreelandTVTimothy Vreeland
- John W. MyersJMJohn W. Myers
- Daniel C. EnsleyDEDaniel C. Ensley
- Diane F. HaleDHDiane F. Hale
- Doreen O. JacksonDJDoreen O. Jackson
- Julia M. GreeneJGJulia M. Greene
- Guy T. CliftonGCGuy T. Clifton
- George E. PeoplesGPGeorge E. Peoples
- Elizabeth A. MittendorfEMElizabeth A. Mittendorf
- 1 October 2017
- journal article
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 225 (4) , S23-S24